Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Abbott, Johnson & Johnson rise; SeaWorld, Carnival Fall

share with twitter share with LinkedIn share with facebook
share via e-mail
03/30/2020 | 04:25pm EDT

NEW YORK (AP) — Stocks that moved heavily or traded substantially on Monday:

Abbott Laboratories, up $4.78 to $79.34.

The medical device maker has a rapid test for the novel coronavirus that can yield results in as little as five minutes.

Carnival Corp., down $1.61 to $12.80.

The cruise line operator is extending its suspension of cruises by a month.

Johnson & Johnson, up $9.85 to $133.01.

The health care products company is moving forward with development of a potential vaccine for COVID-19.

Live Nation Entertainment Inc., down $1.92 to $45.23.

The concert promoter faces a sustained loss of revenue as social distancing guidelines in the U.S. were extended until April 30.

SeaWorld Entertainment Inc., down $2.13 to $11.52.

The theme park operator says it's temporarily furloughing 90% of its workforce as of April 1.

Concho Resources Inc., down $1.03 to $41.08.

Sliding oil prices continued to threaten an array of energy and energy services companies.

Regeneron Pharmaceuticals Inc., up $23.48 to $473.00.

The biotechnology company's partner Sanofi treated the first patient outside the U.S. in a study of a potential COVID-19 treatment.

Tegna Inc., down $2.53 to $10.68.

The television station owner said recent discussions with potential buyers have ended amid the virus pandemic.

Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES 1.19% 91.47 Delayed Quote.5.31%
CARNIVAL CORPORATION & PLC -0.96% 14.46 Delayed Quote.-71.55%
JOHNSON & JOHNSON -1.60% 144.37 Delayed Quote.-1.03%
SEAWORLD ENTERTAINMENT, INC. 1.62% 17.56 Delayed Quote.-44.62%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ABBOTT LABORATORIES
05:45aCovid-19 Tests Come to Work
DJ
05/23WALL STREET WEEK AHEAD : Investors look beyond drug makers as hunt for COVID-19 ..
RE
05/22GLOBAL MARKETS LIVE: Another Chinese company leaving the Nasdaq
05/21ABBOTT : Releases Interim Clinical Study Data on ID NOW COVID-19 Rapid Test Show..
PR
05/21ABBOTT LABORATORIES : Wins Contract to Supply Millions of Antibody Tests to UK G..
DJ
05/21ABBOTT : Announces Contract to Supply Millions of IgG Lab-Based Antibody Tests t..
PR
05/21Board of directors meeting of Abbott Laboratories Limited
AQ
05/21ABBOTT LABORATORIES : Says Health Canada Authorized Antibody Test Under Interim ..
DJ
05/21ABBOTT LABORATORIES : Announces Health Canada Authorization Under the COVID-19 I..
AQ
05/20Election of Directors of Abbott Laboratories Limited
AQ
More news
Financials (USD)
Sales 2020 31 432 M
EBIT 2020 6 114 M
Net income 2020 2 774 M
Debt 2020 11 866 M
Yield 2020 1,56%
P/E ratio 2020 56,9x
P/E ratio 2021 35,2x
EV / Sales2020 5,53x
EV / Sales2021 4,87x
Capitalization 162 B
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 100,63 $
Last Close Price 91,47 $
Spread / Highest target 23,5%
Spread / Average Target 10,0%
Spread / Lowest Target -18,0%
EPS Revisions
Managers
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES5.31%161 796
MASIMO CORPORATION56.07%13 349
ASAHI INTECC CO., LTD.1.25%7 609
NOVOCURE LIMITED-21.70%6 627
GETINGE AB-0.11%4 889
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.50.30%4 435